(Q35245733)

English

Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1 reference

based on heuristic

inferred from title

author name string

Wallace RJ Jr

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Bedsole G

2

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sumter G

3

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sanders CV

4

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Steele LC

5

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Brown BA

6

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Smith J

7

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Graham DR

8

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

language of work or name

0 references

publication date

1 January 1990

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

65-70

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Simple, New Test for Rapid Differentiation of the Mycobacterium fortuitum Complex

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Identification of clinically significant Mycobacterium fortuitum complex isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Spectrum of Disease Due to Rapidly Growing Mycobacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Proposed disk diffusion susceptibility criteria for ofloxacin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Ability of ciprofloxacin but not pipemidic acid to differentiate all three biovariants of Mycobacterium fortuitum from Mycobacterium chelonae

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Human disease due to Mycobacterium smegmatis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Differentiation of Mycobacterium chelonei from M. fortuitum by ciprofloxacin susceptibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Combination of ofloxacin and amikacin in the treatment of sternotomy wound infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

12 July 2018

Clinical Usefulness of Amikacin and Doxycycline in the Treatment of Infection Due to Mycobacterium fortuitum and Mycobacterium chelonei

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

26 September 2018

In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171521

26 September 2018

Sulfonamide Activity Against Mycobacterium fortuitum and Mycobacterium chelonei

1 reference

https://pubmed.ncbi.nlm.nih.gov/2327761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2327761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ofloxacin and the treatment of pulmonary disease due to Mycobacterium fortuitum

1 reference

https://pubmed.ncbi.nlm.nih.gov/2327761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.34.1.65

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35245733&oldid=1575774364"